Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-cell lymphoma (Mycosis Fungoides and Sezary Syndrome)
✍ Scribed by Henry K. Wong; Anjali Mishra; Timothy Hake; Pierluigi Porcu
- Book ID
- 108677427
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 363 KB
- Volume
- 155
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Interleukin‐17 (IL‐17) is a proinflammatory cytokine mainly produced by activated CD4^+^ CD45RO T cells. In mice, we have demonstrated that, depending on the model, IL‐17 may act as a tumor growth‐promoting or ‐inhibiting factor. In order to address the relevance of these models in huma
## BACKGROUND. There is limited published evidence regarding the efficacy of total skin electron beam radiation for patients with the diffuse erythrodermic form of mycosis fungoides. ## METHODS. Forty-five patients with erythrodermic mycosis fungoides were managed at McMaster University in Hamilt
## Background: Data on genome-wide surveys for chromosome aberrations in primary cutaneous t-cell lymphoma (ctcl) are limited. ## Objective: To investigate genetic aberrations in ctcl. ## Methods: We analysed 18 cases of sézary syndrome (ss) and 16 cases of mycosis fungoides (mf) by comparative
Cutaneous T-Cell lymphoma (CTCL) is a non-Hodgkin's lymphoma of unknown pathogenesis. Mycosis fungoides (MF) is a clinically determined subset of CTCL with intensive infiltration of lymphoma cells into the epidermis. To determine whether Epstein-Barr virus (EBV) is associated with these lymphoma cel